This page screens the US healthcare sector for companies with return on assets of at least 10%, refreshed automatically from live data.
DeltaScreener builds this page from the US-listed stocks it tracks, using the following rules. A stock appears here only because it matches these rules; the page title names the criteria and is not a rating of any stock.
Top sectors in the current result set: Healthcare (38).
Click any ticker to open the full stock detail page with financials, valuation ratios, and more.
| # | Ticker | Company | Exchange | Price | Market Cap | P/E | P/B | ROE | ROA | Net Margin | D/E |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RIGL | Rigel Pharmaceuticals, Inc. | NMS | $45.97 | $858.7M | 2.67 | 2.05 | 96.49% | 61.78% | 116.30% | 0.09 |
| 2 | ANAB | AnaptysBio, Inc. | NMS | $46.61 | $1.39B | 7.19 | 134.17 | — | 61.75% | 82.37% | 25.47 |
| 3 | ABUS | Arbutus Biopharma Corporation | NASDAQ | $4.22 | $836.0M | 5.63 | 3.4 | — | 55.85% | 84.23% | 0.01 |
| 4 | LNSR | LENSAR, Inc. | NCM | $5.80 | $71.3M | 5.25 | 5.5 | — | 49.88% | 57.57% | 0.16 |
| 5 | ORMP | Oramed Pharmaceuticals Inc. | NASDAQ | $4.07 | $169.3M | 1.06 | 0.58 | 72.96% | 47.31% | — | 0.01 |
| 6 | RLYB | Rallybio Corporation | NASDAQ | $16.28 | $86.5M | 2.15 | 1.03 | — | 46.45% | — | 0 |
| 7 | AUPH | Aurinia Pharmaceuticals Inc | NASDAQ | $16.51 | $2.20B | 6.71 | 3.35 | 59.00% | 39.65% | 100.84% | 0.1 |
| 8 | FBIO | Fortress Biotech, Inc. | NASDAQ | $1.87 | $62.4M | 0.64 | 0.4 | 103.52% | 35.31% | 163.32% | 0.39 |
| 9 | EXEL | Exelixis, Inc. | NASDAQ | $62.23 | $15.64B | 17.78 | 7.96 | 42.49% | 34.50% | 35.33% | 0.09 |
| 10 | IDXX | IDEXX Laboratories, Inc. | NASDAQ | $560.36 | $44.15B | 36.46 | 25.79 | 71.96% | 33.11% | 25.03% | 0.68 |
| 11 | ASND | Ascendis Pharma A/S - Ordinary Share | NASDAQ | $225.25 | $14.05B | 16.85 | 9.14 | — | 33.08% | 71.69% | 0.31 |
| 12 | QTTB | Q32 Bio Inc. | NASDAQ | $7.52 | $223.9M | 2.95 | 1.1 | 76.88% | 29.16% | 62.87% | 0.05 |
| 13 | NNNN | Anbio Biotechnology | NASDAQ | $3.13 | $137.4M | 32.57 | 9.17 | 27.49% | 28.07% | — | 0 |
| 14 | TGTX | TG Therapeutics, Inc. | NASDAQ | $53.97 | $8.26B | 17.83 | 12.74 | 72.30% | 26.93% | 55.22% | 1.25 |
| 15 | LQDA | Liquidia Corporation | NASDAQ | $34.35 | $3.07B | 19.28 | 13.79 | — | 26.56% | 30.74% | 0.66 |
| 16 | CGEN | Compugen Ltd. | NASDAQ | $1.96 | $185.7M | 6.15 | 2.46 | 42.57% | 25.43% | 47.55% | 0.03 |
| 17 | ADMA | ADMA Biologics Inc | NASDAQ | $10.68 | $2.39B | 14.08 | 5.67 | 39.59% | 24.69% | 32.98% | 0.5 |
| 18 | MEDP | Medpace Holdings, Inc. | NASDAQ | $618.47 | $17.26B | 35.86 | 40.69 | 110.15% | 23.89% | 17.67% | 0.28 |
| 19 | ACAD | ACADIA Pharmaceuticals Inc. | — | $19.12 | $3.29B | 8.87 | 2.62 | 32.39% | 21.83% | 33.42% | 0.06 |
| 20 | INVA | Innoviva, Inc. | NASDAQ | $20.78 | $1.50B | 4.21 | 1.22 | 30.03% | 20.98% | 80.56% | 0.22 |
| 21 | CDNA | CareDx, Inc. | NASDAQ | $64.00 | $3.31B | 30.21 | 7.86 | — | 20.83% | 24.23% | 0.05 |
| 22 | CRMD | CorMedix Inc. | NASDAQ | $7.26 | $565.9M | 3.01 | 1.24 | 44.64% | 20.70% | 40.49% | 0.31 |
| 23 | INCY | Incyte Corporation | NASDAQ | $113.07 | $22.92B | 15.15 | 3.89 | 29.70% | 20.48% | 27.71% | 0.01 |
| 24 | IRMD | iRadimed Corporation | NASDAQ | $88.27 | $1.13B | 47.37 | 10.83 | 23.45% | 20.05% | 26.70% | 0 |
| 25 | MGTX | MeiraGTx Holdings plc | NASDAQ | $9.28 | $891.3M | 17.43 | 5.62 | — | 19.92% | 19.87% | 0.52 |